COVID-19: An Update on Clinical Trials

Curr Top Med Chem. 2020;20(17):1516-1517. doi: 10.2174/1568026620999200511092332.

Authors

Yogesh Kumar¹, Anil Kumar Singh², Shiv Kumar³

Affiliations

¹ Department of Chemistry Bhagini Nivedita College University of Delhi Delhi-110043, India.
² Department of Chemistry School of Physical Sciences Mahatma Gandhi Central University Motihari, Bihar, 845401, India.
³ Jubilant Life Sciences Limited R&D-1, C-26, Sector-59 Noida-201301, India.

PMID: 32394841
DOI: 10.2174/1568026620999200511092332

No abstract available

Publication types

Editorial

MeSH terms

Antiviral Agents / therapeutic use
COVID-19
COVID-19 Vaccines
Clinical Trials as Topic*
Coronavirus Infections / drug therapy*
Coronavirus Infections / prevention & control
Humans
Pandemics
Pneumonia, Viral / drug therapy*
Viral Vaccines

Substances

Antiviral Agents
COVID-19 Vaccines
Viral Vaccines